Background
Individualized diabetes management would benefit from prospectively identifying well-controlled patients at risk of losing glycemic control.
Objectives
To identify patterns of hemoglobin A1c (HbA1c) change among patients with stable controlled diabetes.
Research Design
Cohort study using OptumLabs Data Warehouse, 2001–2013. We develop and apply a machine learning framework that uses a Bayesian estimation of the mixture of generalized linear mixed effect models to discover glycemic trajectories, and a random forest feature contribution method to identify patient characteristics predictive of their future glycemic trajectories.
Subjects
27,005 U.S. adults with type 2 diabetes, age ≥18 years, and stable index HbA1c <7.0%.
Measures
HbA1c values during 24 months of observation.
Results
We compared models with k=1,2,3,4,5 trajectories and baseline variables including patient age, sex, race/ethnicity, comorbidities, medications, and HbA1c. The k=3 model had the best fit, reflecting three distinct trajectories of glycemic change: (T1) rapidly deteriorating HbA1c among 302 (1.1%) youngest (mean, 55.2 years) patients with lowest mean baseline HbA1c, 6.05%; (T2) gradually deteriorating HbA1c among 902 (3.3%) patients (mean, 56.5 years) with highest mean baseline HbA1c, 6.53%; and (T3) stable glycemic control among 25,800 (95.5%) oldest (mean, 58.5 years) patients with mean baseline HbA1c 6.21%. After 24 months, HbA1c rose to 8.75% in T1 and 8.40% in T2, but remained stable at 6.56% in T3.
Conclusions
Patients with controlled type 2 diabetes follow three distinct trajectories of glycemic control. This novel application of advanced analytic methods can facilitate individualized and population diabetes care by proactively identifying high risk patients.